Stock Comparison
ABT vs PHG
Abbott Laboratories and Koninklijke Philips NV ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$26.34B
P/E (TTM)
26.4
23.8
Forward P/E
17.2
15.2
Price/Sales
3.6
1.5
Price/Book
3.2
2.0
EV/EBITDA
16.1
10.7
Dividend Yield
2.62%
3.74%
Profitability
Net Margin
13.90%
5.50%
Operating Margin
13.50%
6.17%
Return on Equity
12.30%
8.36%
Return on Assets
5.59%
3.48%
Growth (YoY)
Revenue Growth
7.80%
-4.70%
Earnings Growth
-19.70%
97.20%
Price & Risk
Beta
0.6
0.9
52-Week High
$135.34
$32.19
52-Week Low
$81.97
$22.86
Analyst Target
$116.54
$33.54
Compare ABT and PHG your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.